About
China Releases 2027-2035 Reform Blueprint for Life Sciences Industry

China’s New Draft Measures for Medical Representatives Tighten Regulatory Compliance

China Finalizes Long-Awaited Drug Domestic Responsible Person (Domestic Agent) Rule

China Implementing Pilot Work Program for Expedited Clinical Trial Review and Approval
China’s NMPA Proposes Medical Device Administration Law

Japan MHLW Publishes Recommendations on the Design and Analysis of Master Protocol Trials

China Issues Proposal on Chemical Drug Pricing to Encourage Pharmaceutical Innovation
